Trial intelligence / Profile preview

Coenzyme Q10 Supplementation in Children with Type 1 Diabetes

NCT06361680Phase 1Not yet recruiting

Sponsor
Assiut University
Start
Oct 2024
Primary completion
Oct 2025
01

Overview

Phase 1, randomised, open-label trial (2 arms), sponsored by Assiut University. Primary endpoint: Glycated Haemoglobin at 1 year. Planned start Oct 2024; status: not yet recruiting.

Beyond the preview

Go deeper on NCT06361680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06361680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call